The sickle disease of 83 percent of adolescents improved after 16 weeks of taking Global Blood Therapeutics‘ voxelotor, preliminary results…
Magdalena Kegel
Magdalena holds an MSc in Pharmaceutical Bioscience and an interdisciplinary PhD merging the fields of psychiatry, immunology and neuropharmacology. Her previous research focused on metabolic and immunologic changes in psychotic disorders. She is now focusing on science writing, allowing her to culture her passion for medical science and human health.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Magdalena Kegel
Researchers at Mississippi State University (MSU) are using tiny polymer chips to build models to help them better understand sickle…
A 13-year-old boy with sickle cell disease has become the world’s first patient to be successfully treated with gene therapy.
Intensifying treatment with hydroxyurea in young children with sickle cell anemia is safe and improves several disease parameters in the…
Removing the spleen by keyhole surgery is a feasible option for children with sickle cell disease, according to a study…
Researchers were able to mend the mutated gene that causes sickle cell disease, and successfully transfer the corrected stem cells into…
In a discovery that appears to turn textbook knowledge on its head, researchers at Massachusetts General Hospital and Harvard Medical…
Women with sickle cell disease have a high risk of complications during pregnancy, according to new research from French Guiana.